Moderna

Makes mRNA vaccines, including its Spikevax COVID-19 shot.

Sold almost all

What the manager says

In short: Bought around $25 after a 95% crash; sold in the $140s after a cancer-vaccine trial success.

Share of the fund

Not disclosed

Named in

Aug 2026 blog post

Also owned by

No other fund we follow

More about Moderna

This fund doesn’t file the government report, so share counts aren’t public.

Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works